HUP0201609A3 - Benzoxazine derivatives as progesterone receptor modulators - Google Patents

Benzoxazine derivatives as progesterone receptor modulators

Info

Publication number
HUP0201609A3
HUP0201609A3 HU0201609A HUP0201609A HUP0201609A3 HU P0201609 A3 HUP0201609 A3 HU P0201609A3 HU 0201609 A HU0201609 A HU 0201609A HU P0201609 A HUP0201609 A HU P0201609A HU P0201609 A3 HUP0201609 A3 HU P0201609A3
Authority
HU
Hungary
Prior art keywords
receptor modulators
progesterone receptor
benzoxazine derivatives
benzoxazine
derivatives
Prior art date
Application number
HU0201609A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Wyeth Five Giralda Farms Madis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,633 external-priority patent/US6509334B1/en
Application filed by Wyeth Five Giralda Farms Madis filed Critical Wyeth Five Giralda Farms Madis
Publication of HUP0201609A2 publication Critical patent/HUP0201609A2/hu
Publication of HUP0201609A3 publication Critical patent/HUP0201609A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0201609A 1999-05-04 2000-05-01 Benzoxazine derivatives as progesterone receptor modulators HUP0201609A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18301299P 1999-05-04 1999-05-04
US09/552,633 US6509334B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate derivatives as progesterone receptor modulators

Publications (2)

Publication Number Publication Date
HUP0201609A2 HUP0201609A2 (en) 2002-08-28
HUP0201609A3 true HUP0201609A3 (en) 2002-12-28

Family

ID=26878647

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201609A HUP0201609A3 (en) 1999-05-04 2000-05-01 Benzoxazine derivatives as progesterone receptor modulators

Country Status (19)

Country Link
EP (1) EP1173426A1 (cg-RX-API-DMAC10.html)
JP (1) JP2002543193A (cg-RX-API-DMAC10.html)
KR (1) KR20010114250A (cg-RX-API-DMAC10.html)
CN (1) CN1145618C (cg-RX-API-DMAC10.html)
AU (1) AU766428B2 (cg-RX-API-DMAC10.html)
BG (1) BG106079A (cg-RX-API-DMAC10.html)
BR (1) BR0010213A (cg-RX-API-DMAC10.html)
CA (1) CA2371726A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ20013951A3 (cg-RX-API-DMAC10.html)
EA (1) EA004512B1 (cg-RX-API-DMAC10.html)
HU (1) HUP0201609A3 (cg-RX-API-DMAC10.html)
IL (1) IL146280A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA01011286A (cg-RX-API-DMAC10.html)
NO (1) NO321361B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ515355A (cg-RX-API-DMAC10.html)
PL (1) PL351127A1 (cg-RX-API-DMAC10.html)
SG (1) SG114650A1 (cg-RX-API-DMAC10.html)
SK (1) SK15912001A3 (cg-RX-API-DMAC10.html)
TR (1) TR200103286T2 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5108506B2 (ja) * 2004-04-27 2012-12-26 ワイス・エルエルシー シアノピロール含有環式カルバメートおよびチオカルバメートビアリール、およびこれらの製造方法
US20100160304A1 (en) * 2005-01-19 2010-06-24 Dainippon Sumitomo Pharma Co., Ltd Aromatic sulfone compound as aldosterone receptor modulator
WO2009044788A1 (ja) 2007-10-05 2009-04-09 Banyu Pharmaceutical Co., Ltd. ベンゾオキサジノン誘導体
CN111925353B (zh) * 2020-08-31 2022-04-08 苏州大学附属第二医院 一种2-噻吩甲腈的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
AU717251B2 (en) * 1994-12-22 2000-03-23 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
DE69724630T2 (de) * 1996-10-02 2004-07-29 Bristol-Myers Squibb Pharma Co. 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv-reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
CA2371726A1 (en) 2000-11-09
NZ515355A (en) 2004-02-27
AU4688600A (en) 2000-11-17
EA004512B1 (ru) 2004-04-29
SG114650A1 (en) 2005-09-28
PL351127A1 (en) 2003-03-24
EA200101176A1 (ru) 2002-04-25
TR200103286T2 (tr) 2002-07-22
NO20015378L (no) 2002-01-03
CZ20013951A3 (cs) 2002-05-15
MXPA01011286A (es) 2003-07-14
CN1145618C (zh) 2004-04-14
BG106079A (en) 2002-05-31
SK15912001A3 (sk) 2002-06-04
NO20015378D0 (no) 2001-11-02
BR0010213A (pt) 2002-02-19
HUP0201609A2 (en) 2002-08-28
IL146280A0 (en) 2002-07-25
AU766428B2 (en) 2003-10-16
JP2002543193A (ja) 2002-12-17
CN1349517A (zh) 2002-05-15
EP1173426A1 (en) 2002-01-23
NO321361B1 (no) 2006-05-02
KR20010114250A (ko) 2001-12-31

Similar Documents

Publication Publication Date Title
HUP0204029A3 (en) Triphenylalkene derivatives and their use as selective estrogen receptor modulators
EG25606A (en) Glucocorticoid receptor modulators
IL146223A0 (en) Steroid derivatives
AU2001296799A1 (en) Benzimidazole and indole derivatives as crf receptor modulators
HUP0203680A3 (en) Controlled release hydrocodone formulations
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
MXPA01011294A (es) Compuestos moduladores de receptor de progesterona tetraciclicos y metodos.
IL154984A0 (en) Estrogen receptor modulators
IL144031A0 (en) Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
HUP0203332A3 (en) Cyclothiocarbamate derivatives, their use as progesterone receptor modulators and pharmaceutical compositions containing them
AU2441801A (en) Urotensin-ii receptor antagonists
IL146151A0 (en) Human-g-protein receptor
IL130169A0 (en) Indole derivatives
ZA200405653B (en) Tetracyclic heterocompounds as estrogen receptor modulators
HUP0202479A3 (en) Indole derivatives
AU5787201A (en) Compounds active at the glucocorticoid receptor
IL146280A0 (en) Cyclocarbamate derivatives as progesterone receptor modulators
AU2574801A (en) Selective iGLUR5 receptor antagonists
GB9927215D0 (en) Hormone receptor expression
AU2818200A (en) Homology models of the glucocorticoid receptor
ZA200107630B (en) Cyclocarbamate derivatives as progesterone receptor modulators.
ZA200107633B (en) Cyclothiocarbamate derivatives as progesterone receptor modulators.
HK1043789A1 (zh) 作为黄体酮受体调节剂的环硫代胺基甲酸盐衍生物
HK1043989A1 (zh) 作为黄体酮受体调节剂的环胺基甲酸盐衍生物
MXPA01011310A (es) Derivados de quinazolinona y benzoxazina como moduladores del receptor de progesterona.

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: WYETH, FIVE GIRALDA FARMS, US

Free format text: FORMER OWNER(S): AMERICAN HOME PRODUCTS CORPORATION, US; LIGAND PHARMACEUTICALS INCORPORATED, US; WYETH, FIVE GIRALDA FARMS, US

FD9A Lapse of provisional protection due to non-payment of fees